Sutinat 50mg Sunitinib Price USA | Ernest Impex Indian Exporter

Sutinat 50mg Capsule: High-Efficiency Tyrosine Kinase Inhibition for Global Oncology Markets

Are you searching for a trusted Sutinat 50 mg capsule exporter from India? Ernest Impex, a core division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted oncology therapies. We facilitate a high-integrity, cold-chain-compliant supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical multi-kinase inhibitors reach medical institutions with pharmaceutical-grade precision.

Detailed Product Overview: What is Sutinat 50mg?

Sutinat 50mg Capsule contains Sunitinib, a powerful oral multi-targeted tyrosine kinase inhibitor (TKI). Manufactured by Natco Pharma Ltd., one of India’s leading oncology specialists, Sutinat is a high-quality pharmaceutical designed to block the signals that allow cancer cells to grow, multiply, and form new blood vessels.

For international B2B procurement, Sutinat 50mg is a vital component in treating advanced solid tumors that have become resistant to standard first-line therapies.

Primary Therapeutic Indications

Sutinat 50 mg is clinically utilized across the globe for:

1. Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to Imatinib Mesylate.

2. Advanced Renal Cell Carcinoma (RCC): Used as a primary treatment for metastatic kidney cancer.

3. Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable locally advanced or metastatic disease.

Mechanism of Action: Advanced Signal Transduction Inhibition

Sutinat 50 mg works through a sophisticated pharmacological process known as Multi-Kinase Inhibition:

• Receptor Blockade: Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), including all receptors for vascular endothelial growth factors (VEGFR-1, -2, and -3) and platelet-derived growth factors (PDGFR-α and -β).

• Anti-Angiogenesis: By blocking VEGFR, Sutinat prevents the tumor from forming new blood vessels, essentially "starving" the tumor of the nutrients required to survive.

• Direct Anti-Tumor Activity: It targets the KIT (stem cell factor receptor) and FLT3, which are critical in the growth of gastrointestinal and hematological malignancies.

• Pathway Suppression: This dual action of attacking both the tumor cells and the tumor blood supply makes it an exceptionally effective targeted therapy.

Administration and Clinical Safety

• Dosage: Sutinat 50 mg is typically taken orally, once daily. For GIST and RCC, it is often administered on a schedule of 4 weeks on treatment followed by 2 weeks off.

• Storage: Store at room temperature (20°C to 25°C). Ensure the container is tightly closed to protect from moisture.

• Key Monitoring:

• Hepatotoxicity: Liver function tests (ALT, AST, Bilirubin) should be monitored regularly.

• Hypertension: Blood pressure should be checked at every clinical visit.

• Cardiovascular Health: Left ventricular ejection fraction (LVEF) monitoring is recommended.

• Thyroid Function: Monitoring for hypothyroidism is standard clinical practice.

Why Source Sutinat 50 mg from Ernest Impex?

• Authentic Natco Oncology Exporter: Direct access to genuine Natco Pharma inventory, ensuring 100% product authenticity and competitive wholesale pricing for global markets.

• Global Logistics Hub: We specialize in the complex documentation and cold-chain logistics required for shipping oncology meds to Washington, London, Bangkok, Canberra, Singapore, and Kingston.

• Regulatory Compliance: We provide all essential B2B documentation, including GMP compliance, batch-specific COAs, and necessary international export permits.

• Bulk Supply Stability: We specialize in large-scale fulfillment for hospital networks, oncology centers, and regional pharmaceutical distributors.